大冢制药

Otsuka Pharmaceutical is a leading global healthcare company headquartered in Japan, operating as a core subsidiary of Otsuka Holdings. The company is dedicated to a corporate philosophy of Otsuka-people creating new products for better health worldwide, focusing on two main business pillars: pharmaceuticals and nutraceuticals. Its pharmaceutical division targets significant unmet medical needs in neuroscience, nephrology, oncology, and cardiovascular diseases, producing blockbuster treatments such as Abilify and Jynarque. Otsuka is also a pioneer in digital medicine, having developed the first FDA-approved drug with an embedded sensor system. With a robust global R&D network and numerous international subsidiaries, the company continues to expand its innovative pipeline through both internal development and strategic biotechnology acquisitions.